NovaMed - helping clients realize the China Opportunity.

Demand - China's large population, growing economy, and increasing diagnostic and treatment rates will soon make China world's 4th largest market for pharmaceutical products. 
     China's Healthcare Spending Has Outpaced GDP Growth...
     Core Growth Drivers
Supply - China's low cost base and abundant talent have the potential to disrupt the traditional supply chain.
     China's Low Cost And Abundant Talent Has Potential to Disrupt the Global Pharmaceutical Industry
     The Market Is Complex, Diverse and Fragmented
Product Lifecycle 
     In China, products classically display a very different product lifecycle than in other...